Draft guidance on management of rolling reviews for drug submissions: Applying for rolling review status

To apply for rolling review status for a forthcoming new drug submission (NDS) or supplement to a new drug submission (SNDS), sponsors must provide a Rolling Review Application Package (RRAP). The RRAP is forwarded to the appropriate directorate and assessed within 45 calendar days.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data